Rolando Ruiz-Vega

Quest Diagnostics (United States)

Papers

1

Total Citations

26

H-Index

1

About

Dr. Rolando Ruiz-Vega is a clinical molecular biologist whose work bridges the critical gap between high-throughput genomics and real-world pandemic response. His primary research focuses on viral genomics, next-generation sequencing (NGS) methodologies, and the rapid detection of emerging pathogens. Dr. Ruiz-Vega’s most significant contribution is the development and validation of a high-throughput SARS-CoV-2 whole genome sequencing workflow designed for clinical laboratories. This work, published in 2022 and cited 26 times, established a robust, scalable protocol that enables the continuous monitoring of new viral mutations. By providing a practical framework for identifying diagnostic and therapeutic targets, his research has directly informed more effective COVID-19 control strategies. The impact of this achievement lies in its translation of complex NGS technology into a deployable clinical tool, empowering labs to track viral evolution in near-real-time. Dr. Ruiz-Vega’s efforts exemplify how methodical assay validation can accelerate public health responses, making him a key figure in the ongoing effort to harness genomic surveillance for infectious disease management.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory
26 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Quest Diagnostics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago